Hamilton Thorne Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Kate Torchilin
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 1.5yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
A Piece Of The Puzzle Missing From Hamilton Thorne Ltd.'s (TSE:HTL) 47% Share Price Climb
Jul 29
These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Reasonably Well
Aug 15At CA$1.40, Is Hamilton Thorne Ltd. (CVE:HTL) Worth Looking At Closely?
May 25Is Hamilton Thorne (CVE:HTL) Using Too Much Debt?
Mar 30These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Safely
Oct 05Should You Think About Buying Hamilton Thorne Ltd. (CVE:HTL) Now?
Jun 10Hamilton Thorne (CVE:HTL) Will Be Hoping To Turn Its Returns On Capital Around
May 15Is Hamilton Thorne (CVE:HTL) A Risky Investment?
Apr 12Estimating The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL)
Mar 15When Should You Buy Hamilton Thorne Ltd. (CVE:HTL)?
Mar 01Has Hamilton Thorne (CVE:HTL) Got What It Takes To Become A Multi-Bagger?
Feb 01Announcing: Hamilton Thorne (CVE:HTL) Stock Soared An Exciting 590% In The Last Five Years
Jan 19Are Insiders Selling Hamilton Thorne Ltd. (CVE:HTL) Stock?
Jan 06What Did Hamilton Thorne's (CVE:HTL) CEO Take Home Last Year?
Dec 24
We Think Hamilton Thorne (CVE:HTL) Can Stay On Top Of Its Debt
Dec 12Is It Time To Consider Buying Hamilton Thorne Ltd. (CVE:HTL)?
Nov 30A Look At The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL)
Nov 17CEO
Kate Torchilin
less than a year
Tenure
Dr. Ekaterina Torchilin PhD, MBA, also known as Kate, is President, Chief Executive Officer and Director of Hamilton Thorne Ltd. from January 15, 2024. She served as Chief Executive Officer of Biocell Cent...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 13.2yrs | US$1.27m | 2.13% CA$ 7.4m | |
| Chief Financial Officer | 2.2yrs | US$476.26k | 0.025% CA$ 85.0k | |
| Vice President of Corporate Development | no data | US$395.95k | 0.021% CA$ 71.7k | |
| Senior VP & GM of HT Inc. | 3.5yrs | US$391.30k | no data | |
| Managing Director of Gynemed | no data | US$247.11k | no data | |
| President | less than a year | no data | no data | |
| Senior Vice President Global Operations & Sustaining Engineering and Management Rep | no data | US$165.49k | no data | |
| Director of HR | no data | no data | no data | |
| President of Embryotech Laboratories Inc | no data | no data | no data | |
| Chief Executive Officer of Gynemed | no data | US$282.51k | no data | |
| Finance Controller | no data | no data | no data |
1.5yrs
Average Tenure
Experienced Management: HTL's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 13.2yrs | US$1.27m | 2.13% CA$ 7.4m | |
| President | less than a year | no data | no data | |
| Lead Independent Director | 15.1yrs | US$113.50k | 0.32% CA$ 1.1m | |
| Independent Director | 15.1yrs | US$66.00k | 13.15% CA$ 45.5m | |
| Independent Director | 17.7yrs | US$103.50k | 0.17% CA$ 583.1k | |
| Independent Director | 2.8yrs | US$113.50k | 0.060% CA$ 207.7k | |
| Independent Director | 7.8yrs | US$66.00k | 0.095% CA$ 329.2k | |
| Independent Director | 3.8yrs | US$66.00k | 0.062% CA$ 213.5k | |
| Chairman Emeritus | 2.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.6yrs | no data | no data | |
| Independent Director | 3.8yrs | US$113.50k | 0.064% CA$ 219.9k | |
| Member of Scientific Advisory Board | 3.6yrs | no data | no data |
3.8yrs
Average Tenure
71yo
Average Age
Experienced Board: HTL's board of directors are considered experienced (3.8 years average tenure).